mediastinal lymphoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 15 = 10 mm in the short axis, as identified by thoracic CT or PET-CT; 4. Patients must have completed all required preoperative laboratory tests and necessary examinations (e.g., cardiac ultrasound, CTA) to rule out contraindications; 5. Patients are informed and capable of providing written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with newly diagnosed lymphoma from whom sufficient pathological tissue can be obtained via superficial lymph node biopsy; 2. Contraindications to endoscopic procedures, such as severe cardiopulmonary disease, coagulation disorders, anesthesia intolerance, uncontrolled psychiatric conditions; 3. Intraoperative endobronchial ultrasound exploration of the lesion failed to detect the target lesion despite > 20 minutes of attempts; 4. Lesions with abundant blood supply or near large vessels or other conditions detected by ultrasound which indicate high risks to continue the biopsy; 5. Lesions confirmed as cysts or abscesses by the ultrasound; 6. Patients who have participated in other clinical trials within 3 months; 7. Any other conditions considered to be inappropriate to be involved in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diagnostic yield;Incidence of adverse events; | — |
Secondary
| Measure | Time frame |
|---|---|
| diagnostic safety;sample adequacy;sample size;operation time;Time consuming operation;Sensitivity;Specificity; | — |
Countries
China
Contacts
The Second Affiliated Hospital of Army Medical University (Xinqiao Hospital)